The Abrdn World Healthcare Fund (NYSE: THW) is a closed-end investment company that seeks long-term capital appreciation through a diversified portfolio of global healthcare equities. Managed by Abrdn plc, a London-based asset management firm with a multi-national footprint, THW focuses on companies operating in pharmaceutical development, biotechnology research, medical devices, healthcare services and related segments. Its flexible mandate allows investment in both large-cap industry leaders and emerging innovators across developed and select emerging markets.
Since its inception in 1998, THW has strived to combine thematic insight into demographic trends with rigorous company-level analysis. Historical allocations have reflected shifting healthcare imperatives—from chronic disease management and specialty therapeutics to digital health solutions and precision medicine. The fund’s research process encompasses clinical pipeline assessment, competitive positioning reviews and regulatory environment monitoring, enabling portfolio managers to identify companies poised for sustainable growth.
Geographically, the fund maintains a broad footprint, with significant exposure to North America, Western Europe and parts of Asia, while also allocating opportunistically to high-growth markets where healthcare infrastructure and innovation are accelerating. Sector weightings typically include established pharmaceutical giants, fast-growing biotech firms, medical technology developers and diversified healthcare service providers. This blend seeks to balance the defensive characteristics of large-cap names with the growth potential of smaller, niche players.
A dedicated team of healthcare equity specialists at Abrdn oversees THW’s investment strategy, integrating environmental, social and governance (ESG) factors where material. The fund employs prudent portfolio construction techniques and may utilize leverage to pursue enhanced returns and manage risk. Traded on the New York Stock Exchange, THW offers investors continuous market liquidity and access to a professionally managed, globally diversified healthcare equity portfolio.
AI Generated. May Contain Errors.
